Journal of Hematology & Oncology | Most Viewed

Submit a manuscript Register

Explore journal

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 7239 Accesses	Review Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options Gerhard J Molderings, Stefan Brettner, Jürgen Homann, Lawrence B Afrin Journal of Hematology & Oncology 2011, 4:10 (22 March 2011) Abstract \| Full text \| PDF \| PubMed
	2. 6152 Accesses	Research Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function Wing Chan, Christopher Cheung, Helen Law, Yu Lau, Godfrey Chan Journal of Hematology & Oncology 2008, 1:9 (21 July 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	3. 5513 Accesses	Review The effects of β-glucan on human immune and cancer cells Godfrey Chan, Wing Chan, Daniel Sze Journal of Hematology & Oncology 2009, 2:25 (10 June 2009) Abstract \| Full text \| PDF \| PubMed
	4. 5204 Accesses	Review Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP Yuan Yuan, Yu-Min Liao, Chung-Tsen Hsueh, Hamid R Mirshahidi Journal of Hematology & Oncology 2011, 4:16 (20 April 2011) Abstract \| Full text \| PDF \| PubMed
	5. 4794 Accesses	Review Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs Subhash Padhye, Aamir Ahmad, Nikhil Oswal, Fazlul H Sarkar Journal of Hematology & Oncology 2009, 2:38 (2 September 2009) Abstract \| Full text \| PDF \| PubMed
	6. 4293 Accesses	Review Mechanism of action of lenalidomide in hematological malignancies Venumadhav Kotla, Swati Goel, Sangeeta Nischal, Christoph Heuck, Kumar Vivek, Bhaskar Das, Amit Verma Journal of Hematology & Oncology 2009, 2:36 (12 August 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	7. 4125 Accesses	Review First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib Guoqing Wei, Shamudheen Rafiyath, Delong Liu Journal of Hematology & Oncology 2010, 3:47 (26 November 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	8. 4117 Accesses	Review Unfolded protein response in cancer: the Physician's perspective Xuemei Li, Kezhong Zhang, Zihai Li Journal of Hematology & Oncology 2011, 4:8 (23 February 2011) Abstract \| Full text \| PDF \| PubMed
	9. 3982 Accesses	Research R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature Ganguly Siddhartha, Patel Vijay Journal of Hematology & Oncology 2009, 2:14 (24 March 2009) Abstract \| Full text \| PDF \| PubMed
	10. 3296 Accesses	Review Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space A Oliver Sartor Journal of Hematology & Oncology 2011, 4:18 (23 April 2011) Abstract \| Full text \| PDF \| PubMed
	11. 3191 Accesses	Review Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors Matthew H Kulke, Johanna Bendell, Larry Kvols, Joel Picus, Rodney Pommier, James Yao Journal of Hematology & Oncology 2011, 4:29 (14 June 2011) Abstract \| Full text \| PDF \| PubMed
	12. 3155 Accesses	Review Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications Shinichiro Takahashi Journal of Hematology & Oncology 2011, 4:13 (1 April 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	13. 3063 Accesses	Review Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy RuiRong Yuan, Andrea Kay, William J Berg, David Lebwohl Journal of Hematology & Oncology 2009, 2:45 (27 October 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	14. 3000 Accesses	Review From basic research to clinical development of MEK1/2 inhibitors for cancer therapy Christophe Frémin, Sylvain Meloche Journal of Hematology & Oncology 2010, 3:8 (11 February 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	15. 2958 Accesses	Research Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663 Pan Jian, Zhao Li, Tao Fang, Wang Jian, Zhou Zhuan, Liao Mei, Wu Yan, Ni Jian Journal of Hematology & Oncology 2011, 4:20 (25 April 2011) Abstract \| Full text \| PDF \| PubMed
	16. 2947 Accesses	Research BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance Hilmar Quentmeier, Sonja Eberth, Julia Romani, Margarete Zaborski, Hans G Drexler Journal of Hematology & Oncology 2011, 4:6 (7 February 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	17. 2775 Accesses	Review Current findings for recurring mutations in acute myeloid leukemia Shinichiro Takahashi Journal of Hematology & Oncology 2011, 4:36 (14 September 2011) Abstract \| Full text \| PDF \| PubMed
	18. 2738 Accesses	Review Treatment options for patients with triple-negative breast cancer Rafael Santana-Davila, Edith A Perez Journal of Hematology & Oncology 2010, 3:42 (27 October 2010) Abstract \| Full text \| PDF \| PubMed
	19. 2634 Accesses	Case report Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature Utkarsh Acharya, Jen-Tzer Gau, William Horvath, Paolo Ventura, Chung-Tsen Hsueh, Wayne Carlsen Journal of Hematology & Oncology 2008, 1:26 (18 December 2008) Abstract \| Full text \| PDF \| PubMed
	20. 2621 Accesses	Research A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma Jing Hu, Gang Zhao, Hong-Xia Wang, Lei Tang, Ying-Chun Xu, Yue Ma, Feng-Chun Zhang Journal of Hematology & Oncology 2011, 4:11 (26 March 2011) Abstract \| Full text \| PDF \| PubMed
	21. 2563 Accesses	Research Rosai dorfman disease of the orbit Geeta K Vemuganti, Milind N Naik, Santosh G Honavar Journal of Hematology & Oncology 2008, 1:7 (28 June 2008) Abstract \| Full text \| PDF \| PubMed
	22. 2465 Accesses	Review Endothelial progenitor cell biology in disease and tissue regeneration Andrea L George, Pradeep Bangalore-Prakash, Shilpi Rajoria, Robert Suriano, Arulkumaran Shanmugam, Abraham Mittelman, Raj K Tiwari Journal of Hematology & Oncology 2011, 4:24 (24 May 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	23. 2430 Accesses	Research Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis Bernardo HL Goulart, Jeffrey W Clark, Gregory Y Lauwers, David P Ryan, Nina Grenon, Alona Muzikansky, Andrew X Zhu Journal of Hematology & Oncology 2009, 2:13 (16 March 2009) Abstract \| Full text \| PDF \| PubMed
	24. 2386 Accesses	Research Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib Hua Cheng, She-Juan An, Song Dong, Yi-Fang Zhang, Xu-Chao Zhang, Zhi-Hong Chen, Jian-Su, Yi-Long Wu Journal of Hematology & Oncology 2011, 4:5 (21 January 2011) Abstract \| Full text \| PDF \| PubMed
	25. 2298 Accesses	Research Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells Ratana Banjerdpongchai, Prachya Kongtawelert, Orawan Khantamat, Chantragan Srisomsap, Daranee Chokchaichamnankit, Pantipa Subhasitanont, Jisnuson Svasti Journal of Hematology & Oncology 2010, 3:50 (30 December 2010) Abstract \| Full text \| PDF \| PubMed